Financial statements Neurosolutions
Balance sheet data of NEUROSOLUTIONS
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 1 506 463,46 | 777 705,70 | 513 294,21 |
| A. Fixed assets | 957 082,31 | 712 284,28 | 467 486,20 |
| B. Current assets | 549 381,15 | 65 421,42 | 45 808,01 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 506 463,46 | 777 705,70 | 513 294,21 |
| A. Equity | -424,54 | -254 551,03 | -432 966,29 |
| B. Liabilities and provisions for liabilities | 1 506 888,00 | 1 032 256,73 | 946 260,50 |
| I. Long-term liabilities | 1 500 000,00 | 984 993,00 | 944 158,50 |
| II. Short-term liabilities | 6 888,00 | 47 263,73 | 2 102,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.